Background

Feline allergies are a common source of allergens, affecting up to 15% of adults and children and causing symptoms such as rhinoconjunctivitis and severe asthma [1-3]. Data from the U.S. National Health and Nutrition Examination Survey indicates that over 5 million asthma attacks occur each year, with ~350,000 emergency room visits attributed to patients sensitized and exposed to feline allergens [4].

Sensitization to the major feline allergen, Fel d 1 (Felis domesticus allergen 1), elicits IgE responses in >90% of cat-allergic individuals [5]. Feline allergens are produced by the sebaceous, salivary, and lacrimal glands of cats, and the highest Fel d 1 levels are found in saliva. When cats groom themselves, Fel d 1 is transferred from saliva to their hair, and cat dander containing Fel d 1 allergen is then spread to the environment as small airborne particles [6-11].

Furthermore, the small size and structure of Fel d 1 allows it to be easily and continuously airborne for long periods of time, making it one of the easiest allergens to inhale. Its molecular structure also allows it to adhere to fabrics, carpets, and upholstered furniture [11, 13-16]. These factors can make it difficult to remove Fel d 1 from homes, and allow it to travel on clothing and other items from cat-owning households to places where no cat is present. Fel d 1 can be found in homes and buildings without cats, especially in communities where cat owners live [17], causing serious cat allergic problems.

Despite the prevalence and potential severity of feline allergic disease, current treatments merely address the allergic symptoms (e.g., antihistamines) or have demonstrated inconsistent results (e.g., feline allergen immunotherapy [18, 19]).

Inspiration

Outside the laboratory building of our team lives a Cat called "Dean". He is so cute and tsundere, attracting students to stop to admire his charmable appearance, and sometimes also touch him, to feed him some cat strips and cat cans. One member of the iGEM team this year is a devoted cat lover, but can only watch from a distance with envy because she is allergic to cat.

During the brainstorming phase, we realized that by preventing cat allergies, we could give more people who want to own a cat a chance. Under this idea, we investigated the existing treatment and prevention methods in the market, considered the feasibility of using antibodies for treatment and the benefits of commercialization, and finally confirmed the theme of this year's project.

Our project

The name of our project is C.A.T: Cat Allergic Therapy. As the name suggests, we hope to use synthetic biology to address the problem of people who want to own cats but they couldn't because of suffering from allergies. Our project targets the cat itself. By treating with our products, cats will have fewer allergens, then making the people who are allergic to cats can also keep them at ease.

Colonization

This module enables our engineered bacteria to live in the cat's mouth for an extended period of time. Hsa, a protein that the Streptococcus gordonii str. Challis uses to stick to the teeth, is used in this part [20]. By recognizing components containing sialic acid, Hsa makes our engineered bacteria adhere to the saliva pellicle [21].

Regulation and Blocking

As a quorum sensing(QS) signaling molecule, 3,5-Dimethyl-Pyrazin-2-OL (DPO)'s concentration can be sensed by the engineered bacteria through the membrane protein VqmA [22, 23]. Once the concentration reaches a certain level, the colonization module is closed while the blocking module is opened, avoiding the excessive biofilm formation. Blocking module consists mainly of two single-chain fragment variables (scFvs) secreted outside the cell [24]. These scFvs block the immune response caused by the antigen and prevent allergies.

Sterilization

This module is based on the two-component quorum sensing system of Streptococcus mutans, ComDE, and bactericidal proteins specific to S. mutans [25]. S. mutans is the main pathogen in dental plaque [26]. In order to prevent the biofilm formed by engineered bacteria on teeth from being used by S. mutans, engineered bacteria use the ComDE two-component system (TCS) to sense S. mutans' ability to competence-stimulating peptide (CSP) production when S. mutans concentration is high, and affects the downstream loop to express ClyR [27, 28], which destroys the biofilm on the tooth surface and kills S. mutans.

Suicide

Our project adds a suicide module to prevents our engineered bacteria from leaking into the environment and prevent engineered bacteria from entering the cat's body through the digestive tract. If engineered bacteria get out of the environment it's supposed to be in, the suicide module turns on.

[1] Ingram JM, Sporik R, Rose G, Honsinger R, Chapman MD, Platts-Mills TA. Quantitative assessment of exposure to dog (Can f 1) and cat (Fel d 1) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol. 1995 Oct;96(4):449-56.

[2] Chan SK, Leung DYM. Dog and Cat Allergies: Current State of Diagnostic Approaches and Challenges. Allergy Asthma Immunol Res. 2018 Mar;10(2):97-105.

[3] Suzuki S, Nwaru BI, Ekerljung L, Sjölander S, Mincheva R, Rönmark EP, Rönmark E, Lundbäck B, Borres MP, Lötvall J. Characterization of sensitization to furry animal allergen components in an adult population. Clin Exp Allergy. 2019 Apr;49(4):495-505.

[4] Gergen PJ, Mitchell HE, Calatroni A, Sever ML, Cohn RD, Salo PM, Thorne PS, Zeldin DC. Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):101-107.e2.

[5] Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498.

[6] Ohman JL Jr, Lowell FC, Bloch KJ. Allergens of mammalian origin. III. Properties of a major feline allergen. J Immunol. 1974 Dec;113(6):1668-77.

[7] van Ree R, van Leeuwen WA, Bulder I, Bond J, Aalberse RC. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J Allergy Clin Immunol. 1999 Dec;104(6):1223-30.

[8] Bartholomé K, Kissler W, Baer H, Kopietz-Schulte E, Wahn U. Where does cat allergen 1 come from? J Allergy Clin Immunol. 1985 Sep;76(3):503-6.

[9] Charpin C, Mata P, Charpin D, Lavaut MN, Allasia C, Vervloet D. Fel d I allergen distribution in cat fur and skin. J Allergy Clin Immunol. 1991 Jul;88(1):77-82.

[10] Dabrowski AJ, Van der Brempt X, Soler M, Seguret N, Lucciani P, Charpin D, Vervloet D. Cat skin as an important source of Fel d I allergen. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 1):462-5.

[11] Ichikawa K, Vailes LD, Pomés A, Chapman MD. Identification of a novel cat allergen--cystatin. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):55-6.

[12] Luczynska CM, Li Y, Chapman MD, Platts-Mills TA. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus). Measurements using cascade impactor, liquid impinger, and a two-site monoclonal antibody assay for Fel d I. Am Rev Respir Dis. 1990 Feb;141(2):361-7.

[13] Liccardi G, D'Amato G, Russo M, Canonica GW, D'Amato L, De Martino M, Passalacqua G. Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. Int Arch Allergy Immunol. 2003 Sep;132(1):1-12.

[14] Duffort OA, Carreira J, Nitti G, Polo F, Lombardero M. Studies on the biochemical structure of the major cat allergen Felis domesticus I. Mol Immunol. 1991 Apr-May;28(4-5):301-9.

[15] Kristensen AK, Schou C, Roepstorff P. Determination of isoforms, N-linked glycan structure and disulfide bond linkages of the major cat allergen Fel d1 by a mass spectrometric approach. Biol Chem. 1997 Aug;378(8):899-908.

[16] Custovic A, Simpson A, Woodcock A. Importance of indoor allergens in the induction of allergy and elicitation of allergic disease. Allergy. 1998;53(48 Suppl):115-20.

[17] Heinrich J, Bedada GB, Zock JP, Chinn S, Norbäck D, Olivieri M, Svanes C, Ponzio M, Verlato G, Villani S, Jarvis D, Luczynska C; Indoor Working Group of the European Community Respiratory Health Survey II. Cat allergen level: its determinants and relationship to specific IgE to cat across European centers. J Allergy Clin Immunol. 2006 Sep;118(3):674-81.

[18] Dhami S, Agarwal A. Does evidence support the use of cat allergen immunotherapy? Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):350-355.

[19] Patel D, Couroux P, Hickey P, Salapatek AM, Laidler P, Larché M, Hafner RP. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J Allergy Clin Immunol. 2013 Jan;131(1):103-9.e1-7.

[20] Nobbs AH, Jenkinson HF, Jakubovics NS. Stick to your gums: mechanisms of oral microbial adherence. J Dent Res. 2011 Nov;90(11):1271-8.

[21] Takahashi Y, Konishi K, Cisar JO, Yoshikawa M. Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect Immun. 2002 Mar;70(3):1209-18.

[22] Gu Y, Zhi SX, Yang N, Yang WS. Understanding the mechanism of asymmetric gene regulation determined by the VqmA of vibriophage. Biochem Biophys Res Commun. 2021 Jun 18;558:51-56.

[23] Mashruwala AA, Bassler BL. The Vibrio cholerae Quorum-Sensing Protein VqmA Integrates Cell Density, Environmental, and Host-Derived Cues into the Control of Virulence. mBio. 2020 Jul 28;11(4):e01572-20.

[24] Orengo JM, Radin AR, Kamat V, Badithe A, Ben LH, Bennett BL, Zhong S, Birchard D, Limnander A, Rafique A, Bautista J, Kostic A, Newell D, Duan X, Franklin MC, Olson W, Huang T, Gandhi NA, Lipsich L, Stahl N, Papadopoulos NJ, Murphy AJ, Yancopoulos GD. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat Commun. 2018 Apr 12;9(1):1421.

[25] Liu, T., Xue, S., Cai, W. et al. ComCED signal loop precisely regulates nlmC expression in Streptococcus mutans . Ann Microbiol. 2014;64:31-38.

[26] Nicolas GG, Lavoie MC. Streptococcus mutans et les streptocoques buccaux dans la plaque dentaire [Streptococcus mutans and oral streptococci in dental plaque]. Can J Microbiol. 2011 Jan;57(1):1-20. French.

[27] van der Ploeg JR. Regulation of bacteriocin production in Streptococcus mutans by the quorum-sensing system required for development of genetic competence. J Bacteriol. 2005 Jun;187(12):3980-9.

[28] Xu J, Yang H, Bi Y, Li W, Wei H, Li Y. Activity of the Chimeric Lysin ClyR against Common Gram-Positive Oral Microbes and Its Anticaries Efficacy in Rat Models. Viruses. 2018 Jul 20;10(7):380.